Home > Press > Purer water made possible by Sandia advance: A single atom makes a big difference
This bar graph shows the efficacy of removing wild-type bacteriophage from Rio Grande water using the all-aluminum coagulant (yellow), the gallium-aluminum coagulant (pink) and a germanium-aluminum coagulant (green). While the gallium-aluminum coagulant is most effective, the germanium-aluminum coagulant is less effective than the all-aluminum coagulant. The gallium makes the active ingredient for binding contaminants more stable and effective, while the germanium, introduced as another variable, was found to make the active ingredient less stable and less effective. |
Abstract:
By substituting a single atom in a molecule widely used to purify water, researchers at Sandia National Laboratories have created a far more effective decontaminant with a shelf life superior to products currently on the market.
Sandia has applied for a patent on the material, which removes bacterial, viral and other organic and inorganic contaminants from river water destined for human consumption, and from wastewater treatment plants prior to returning water to the environment.
"Human consumption of ‘challenged' water is increasing worldwide as preferred supplies become more scarce," said Sandia principal investigator May Nyman. "Technological advances like this may help solve problems faced by water treatment facilities in both developed and developing countries."
The study was published in June 2009 in the journal Environmental Science & Technology (a publication of the American Chemical Society) and highlighted in the June 22 edition of Chemical & Engineering News. Sandia is working with a major producer of water treatment chemicals to explore the commercial potential of the compound.
The water-treatment reagent, known as a coagulant, is made by substituting an atom of gallium in the center of an aluminum oxide cluster — itself a commonly used coagulant in water purification, says Nyman.
The substitution isn't performed atom by atom using nanoscopic tweezers but rather uses a simple chemical process of dissolving aluminum salts in water, gallium salts into a sodium hydroxide solution and then slowly adding the sodium hydroxide solution to the aluminum solution while heating.
"The substitution of a single gallium atom in that compound makes a big difference," said Nyman. "It greatly improves the stability and effectiveness of the reagent. We've done side-by-side tests with a variety of commercially available products. For almost every case, ours performs best under a wide range of conditions."
Wide-ranging conditions are inevitable, she said, when dealing with a natural water source such as a river. "You get seasonal and even daily fluctuations in pH, temperature, turbidity and water chemistry. And a river in central New Mexico has very different conditions than say, a river in Ohio."
The Sandia coagulant attracts and binds contaminants so well because it maintains its electrostatic charge more reliably than conventional coagulants made without gallium, itself a harmless addition.
The new material also resists converting to larger, less-reactive aggregates before it is used. This means it maintains a longer shelf life, avoiding the problem faced by related commercially available products that aggregate over time.
"The chemical substitution [of a gallium atom for an aluminum atom] has been studied by Sandia's collaborators at the University of California at Davis, but nobody has ever put this knowledge to use in an application such as removing water contaminants like microorganisms," said Nyman.
The project was conceived and all water treatment studies were performed at Sandia, said Nyman, who worked with Sandia microbiologist Tom Stewart. Transmission electron microscope images of bacteriophages binding to the altered material were achieved at the University of New Mexico. Mass spectroscopy of the alumina clusters in solution was performed at UC Davis.
The work was sponsored by Sandia's Laboratory Directed Research Development office. Ohio."
####
About Sandia National Laboratories
Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy’s National Nuclear Security Administration. With main facilities in Albuquerque, N.M., and Livermore, Calif., Sandia has major R&D responsibilities in national security, energy and environmental technologies, and economic competitiveness.
For more information, please click here
Contacts:
Neal Singer
(505) 845-7078
Copyright © Sandia National Laboratories
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Laboratories
A battery’s hopping ions remember where they’ve been: Seen in atomic detail, the seemingly smooth flow of ions through a battery’s electrolyte is surprisingly complicated February 16th, 2024
NRL discovers two-dimensional waveguides February 16th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Water
Taking salt out of the water equation October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||